Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minhai Varicella Vaccine in Children (1-12 Years)
NCT06614816Phase 3Completed
- Sponsor
- Southeast University
- Start
- Feb 2019
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varicella vaccine in chickenpox (2 arms), sponsored by Southeast University. Primary endpoint: Seroconversion rate at 42 days. Started Feb 2019; status: completed.
02
Drugs
varicella vaccine
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT06614816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06614816.